Monthly Archives - October 2020

Update Update Update

Startup founders often times underestimate the importance of keeping their investors up to date. The mistake is to only update investors when you need money or you have good news. Investors want and need to know everything the good the bad and the ugly.

At a minimum founders should send a quarterly email update and one yearly in person or remote meeting for Q&A. Investors are known to read updates in great detail simply because they need to know the […]

SAM Sport’s Ability to Help Athletes Recover from Injury Without Surgery is Gaining Recognition from Enthusiasts Within the Tennis Community

SAM Sport, an FDA-cleared bio regenerative medical device that helps reduce pain associated with tendon, ligament, and muscle injuries is receiving an increased amount of attention for its ability to help tennis players recover without surgery. SAM by ZetrOZ Systems provides proven soft tissue and chronic pain relief through continuous ultrasound treatment. Read more >>

eSight 4 Medical Device for the Visually Impaired, Now Available in the United Kingdom, Germany and France

eSight today announces that its newest vision enhancement technology, eSight 4, is now available in select European countries, expanding its goal of providing sight to people with visual impairment on a global basis. The wearable medical device can be purchased in the United Kingdom, Germany and France, with more countries to be added in 2021. eSight 4 obtained its CE Mark in August, meeting the European Union’s standards for health, safety and environmental protections. Read more >>

Supporting Entrepreneurs

Ziad Moukheiber President of Boston Harbor Angels is speaking and participating on panels and workshops at Yale University, Babson College and The Technology Institute of Monterey in Mexico to help entrepreneurs better understand fundraising and the angel investing ecosystem.

“Entrepreneurs often times know their businesses very well and need some support navigating the fundraising world, especially the angel investing industry” says Ziad Moukheiber.

The Boston Harbor Angels community of members is always involved in helping entrepreneurs at all levels and at […]

Kalion Inc. Teams with Agile BioFoundry To Win DOE Grant to Advance Bio-based Glucaric Acid

Kalion Inc., along with 8 other companies, was selected by the U.S. Department of Energy to receive $5.7 million in funding with the Agile BioFoundry consortium (agilebiofoundry.org) to advance the fundamental understanding of industrial biotechnology. Kalion Inc. uses machine learning to accelerate the development of high-purity, low-cost glucaric acid. Read more >>

Boulder JCC Nosh & Network Panel Discussion: Pivot Business To Possibility

On Wednesday, October 28 from 4:00 – 5:30 pm, we will host a panel discussion on the ways in which COVID-19 required businesses to revisit the way their work is done, including reassessing, reshaping, and refocusing. Four Boulder businesses will share their experience and how they expect their business will change going forward. Panel includes 1908 Brands. Read more >>

The Active Fund at Boston Harbor Angels

Boston Harbor Angels launched in 2018 an investment platform for its members and accredited investors ” The Active Fund”.

The Active Fund allows members and accredited investors to invest and support startups in the Boston Harbor Angels ecosystem.

“The Active Fund is a private platform allowing a lot of flexibility to our members” said Ziad Moukheiber President of Boston Harbor Angels.

Kalion Inc. Teams with Agile BioFoundry To Win DOE Grant to Advance Bio-based Glucaric Acid

Kalion Inc., along with 8 other companies, was selected by the U.S. Department of Energy to receive $5.7 million in funding with the Agile BioFoundry consortium (agilebiofoundry.org) to advance the fundamental understanding of industrial biotechnology. Kalion Inc. uses machine learning to accelerate the development of high-purity, low-cost glucaric acid. Read more >>

First Light Diagnostics Receives Additional Funding from the Biomedical Advanced Research and Development Authority (BARDA)

First Light Diagnostics, Inc., a developer of breakthrough automated products for the rapid diagnosis and treatment of life-threatening infections, today announced the authorization of a $4 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. These funds will continue BARDA’s support of First Light Diagnostics’ proprietary MultiPath™ platform and a rapid ultrasensitive test to identify victims […]